Clinical Trial Update: Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT [Phase 2]

View source ↗

Summary

Phase 2 pilot randomized trial evaluating precision dosing of oral ibuprofen for treating patent ductus arteriosus in preterm infants is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus
• Preterm Birth

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Patent Ductus Arteriosus, Preterm | Phase 2 | Status: RECRUITING